Its ability to reduce hepatic glucose production, improve insulin sensitivity, and offer weight neutrality or modest loss has made it a go-to for clinicians
Hepatic Fat Reduction In metabolic dysfunctionassociated steatotic liver disease (MASLD), retatrutide has been studied for its impact on hepatic fat content
Cinco nuevos hallazgos sobre los GLP-1 y el cncer de mama (seno) Los medicamentos con GLP-1, como Ozempic, Trulicity, Victoza, Mounjaro, Wegovy y Zepbound, se calificaron como frmacos milagrosos, no solo por su eficacia para el descenso de peso, sino tambin por los beneficios que aportan a las personas con diabetes, en riesgo de padecer enfermedades cardiovasculares, entre otros
However, this reduced side effect profile reflects reduced efficacy, not superior safety or outcomes